Los Angeles Capital Management
IRMD icon

Los Angeles Capital Management’s iRadimed IRMD Stock Holding History

Los Angeles Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.9K Buy
165
+151
+1,079% +$15.1K ﹤0.01% 1809
2025
Q4 		$1.07K Buy
+14
New +$1.2K ﹤0.01% 2475
2025
Q3 		– Sell
-22,649
Closed -$1.35M – 1444
2025
Q2 		$1.35M Sell
22,649
-11,361
-33% -$623K 0.01% 561
2025
Q1 		$1.78M Sell
34,010
-5,053
-13% -$284K 0.01% 422
2024
Q4 		$2.15M Sell
39,063
-6,000
-13% -$316K 0.01% 436
2024
Q3 		$2.27M Sell
45,063
-4,500
-9% -$208K 0.01% 431
2024
Q2 		$2.18M Buy
49,563
+700
+1% +$29.8K 0.01% 432
2024
Q1 		$2.15M Sell
48,863
-4,438
-8% -$196K 0.01% 481
2023
Q4 		$2.53M Hold
53,301
– – 0.01% 433
2023
Q3 		$2.36M Buy
53,301
+279
+0.5% +$13K 0.01% 407
2023
Q2 		$2.53M Sell
53,022
-1,298
-2% -$58.5K 0.01% 429
2023
Q1 		$2.14M Buy
54,320
+41,554
+326% +$1.51M 0.01% 484
2022
Q4 		$361K Buy
12,766
+3,120
+32% +$89.3K ﹤0.01% 981
2022
Q3 		$290K Buy
9,646
+2,340
+32% +$81.5K ﹤0.01% 1078
2022
Q2 		$248K Sell
7,306
-200
-3% -$7.17K ﹤0.01% 1203
2022
Q1 		$337K Sell
7,506
-7,580
-50% -$351K ﹤0.01% 1189
2021
Q4 		$697K Hold
15,086
– – ﹤0.01% 859
2021
Q3 		$507K Sell
15,086
-1,470
-9% -$50K ﹤0.01% 1035
2021
Q2 		$487K Sell
16,556
-590
-3% -$16.3K ﹤0.01% 1178
2021
Q1 		$442K Sell
17,146
-940
-5% -$22.5K ﹤0.01% 1267
2020
Q4 		$412K Sell
18,086
-1,450
-7% -$33.5K ﹤0.01% 1279
2020
Q3 		$418K Buy
+19,536
New +$439K ﹤0.01% 1155

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Los Angeles Capital Management's IRMD Position: Q1 2026 in Review

Los Angeles Capital Management increased its iRadimed (IRMD) stake by 1,079% in Q1 2026, buying an estimated $15.1K and bringing the position to 165 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1809.

Los Angeles Capital Management first reported a position in IRMD in Q3 2020 and has held it in 22 quarters since. The position peaked at $2.53M in Q2 2023. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Los Angeles Capital Management held 165 shares of iRadimed worth $15.9K as of Q1 2026.
  • Los Angeles Capital Management bought 151 iRadimed shares in Q1 2026, an estimated $15.1K.
  • iRadimed made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1809 holding.
  • Los Angeles Capital Management first reported a position in iRadimed in Q3 2020 and has held it in 22 quarters since.
  • Los Angeles Capital Management's iRadimed position peaked at $2.53M in Q2 2023.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.